Home > Financial Ratios > CIPLA

CIPLA
Core EBITDA Growth

    Back to All Ratios
CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results

CIPLA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 27.9013.836.9827.27-0.66

What is the latest Core EBITDA Growth ratio of CIPLA ?

The latest Core EBITDA Growth ratio of CIPLA is 27.90 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202427.90
Mar202313.83
Mar20226.98
Mar202127.27
Mar2020-0.66

How is Core EBITDA Growth of CIPLA Trending?

Years Core EBITDA Growth % Change
Mar2024 27.9
101.74
Mar2023 13.83
98.14
Mar2022 6.98
-74.40
Mar2021 27.27
Positive
Mar2020 -0.66 -

Other Financial Ratios of CIPLA


Compare Core EBITDA Growth ratio of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹117,832.9 Cr 0.1% 1.2% 3.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,003.0 Cr -1.6% -4.6% 14.7% Stock Analytics
DIVIS LABORATORIES ₹154,939.0 Cr -1.6% -1.3% 61.6% Stock Analytics
DR REDDYS LABORATORIES ₹99,784.6 Cr -2.1% -8.7% -2.3% Stock Analytics
MANKIND PHARMA ₹98,888.9 Cr -4.4% -7.8% 13.3% Stock Analytics
ZYDUS LIFESCIENCES ₹90,722.1 Cr -6.5% -9.3% 8.6% Stock Analytics


CIPLA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

0.1%

1.2%

3.3%

SENSEX

-2.5%

-1.4%

6.1%


You may also like the below Video Courses